IVRS is an innovative preclinical CRO dedicated to accelerating drug discovery and validation for severe human diseases with significant unmet medical needs. Our expertise spans both in vitro and in vivo studies, helping to fast-track the development of breakthrough therapies.
We specialize in advanced animal models for cancer, neurodegenerative diseases, and inflammatory disorders, providing:
- Precise characterization of disease progression
- Continuous monitoring of drug efficacy with high-throughput approaches
- Visual tracking of biodistribution throughout the body and targeted organs
- PK/PD profiling to optimize candidate drug performance
At IVRS, our state-of-the-art technologies and disease models ensure your drug pipeline advances with accuracy and efficiency. Let us support your journey to delivering life-changing treatments.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Scheeletorget 1, Lund,skåne 223 81,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- ivrs.se
- Keywords
- Oncology, In vivo Disease Model, In vivo imaging 3D, Patient-derived studies xenograft (PDX) models, Drug screening, Cell-based Assays.
- HQ
- Lund, Skåne
Ivrs Ab Questions
Ivrs Ab's website is ivrs.se
Ivrs Ab's LinkedIn profile is https://se.linkedin.com/company/ivrs-ab
Ivrs Ab has
6 employees.
View email and phone details for 6
employees at Ivrs Ab.
Ivrs Ab's industry is
Biotechnology Research
Ivrs Ab's top competitors are
Invitro Research Solutions Private Limited,
Medusind,
Oviya Medsafe,
Innovate Research,
Truly Labs,
Navitas Life Sciences,
Ivrs Ltd,
Medilenz,
Trackpaw Scientific Ab,
Acousort Ab.
Ivrs Ab's categories are Biotechnology Research
Ivrs Ab's founding year is 2019
